Haleon (NYSE:HLN) Raised to Buy at Wall Street Zen

Haleon (NYSE:HLN - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued on Friday.

A number of other equities research analysts have also recently commented on HLN. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective on the stock in a research note on Friday, May 9th. Barclays restated an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. HSBC reissued a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a research report on Monday, March 3rd. Finally, Hsbc Global Res lowered Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Five analysts have rated the stock with a hold rating, five have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Haleon presently has a consensus rating of "Moderate Buy" and an average price target of $12.33.

Haleon Stock Performance

Haleon stock traded down $0.05 during midday trading on Friday, hitting $11.07. 13,897,070 shares of the company were exchanged, compared to its average volume of 8,729,754. The business has a fifty day simple moving average of $10.50 and a two-hundred day simple moving average of $10.03. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The firm has a market capitalization of $49.84 billion, a PE ratio of 32.56, a price-to-earnings-growth ratio of 2.82 and a beta of 0.31. Haleon has a fifty-two week low of $8.25 and a fifty-two week high of $11.42.

Institutional Investors Weigh In On Haleon

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Wellington Management Group LLP raised its position in shares of Haleon by 67.5% in the fourth quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock valued at $146,232,000 after buying an additional 6,175,835 shares during the last quarter. Nuveen LLC acquired a new position in shares of Haleon during the 1st quarter worth approximately $58,870,000. Point72 Asset Management L.P. acquired a new stake in shares of Haleon in the fourth quarter valued at approximately $45,110,000. Raymond James Financial Inc. acquired a new stake in shares of Haleon in the fourth quarter valued at approximately $42,193,000. Finally, FMR LLC lifted its position in Haleon by 3.7% during the fourth quarter. FMR LLC now owns 108,827,814 shares of the company's stock worth $1,038,217,000 after buying an additional 3,909,545 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.